课题基金 / 基金详情

The role of MTG8 in transcriptional elongation and leukemia

The role of MTG8 in transcriptional elongation and leukemia
MTG8 在转录延伸和白血病中的作用
批准号:
8456501
负责人:
Kristy Stengel
金额:
$2.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2013-08-31

项目摘要

项目成果

Kristy Stengel的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):t(8;21)染色体易位是急性髓性白血病(AML)中最常见的易位,其结果是AML1-ETO (RUNX1-MTG8)融合蛋白的表达。AML1- ETO (AE)由转录调控因子的n端DNA结合域组成,AML1 (RUNX1)与大部分ETO (MTG8)融合。Mtg8是一个三蛋白家族的成员,包括Mtg16和Mtgr1,它们通过与序列特异性转录因子的相互作用,通过在启动子处组装辅抑制子复合物来介导转录抑制。传统上,AE的表达被认为是通过MTG8转录抑制因子在RUNX1靶基因的异常定位而促进白血病的发生,而RUNX1靶基因是正常血液发育和干细胞自我更新功能所必需的。有趣的是,对人类AML样本的检查显示,除了全长AE外,还检测到低水平的AE剪接变体AML1-ETO9a (AE9a)。AE9a剪接变体编码c端截断,与全长AE相比,在小鼠模型中高度致白血病。这些观察结果提示AE的c端区可能阻碍白血病的发展。因此,我们利用Mtg蛋白的c端片段进行酵母双杂交(Y2H)筛选,以确定可能解释Mtg c端抗白血病功能的新的相互作用伙伴。该筛选确定了Mtg蛋白与调节转录伸长的许多因素之间的新相互作用。重要的是,指向这些伸长因子的sirna补充了Mtg8-/-表型,在功能上连接了这些基因,并表明伸长调节是MTGs的主要功能。此外,血细胞中Mtg16的失活增加了在伸长水平上调节干细胞自我更新的基因。基于这些初步数据,我们假设AE的c端区域通过负面影响转录伸长而作为“抗白血病”结构域。去除该结构域会释放延伸因子,激活靶基因(如HoxA5和HoxA7)的转录。我们的建议旨在充分阐明MTG与延伸因子相关的分子机制,并在“正常”细胞和白血病发生的背景下定义这些相互作用的功能后果。
英文摘要
DESCRIPTION (provided by applicant): The t(8;21) chromosomal translocation is the most frequently observed translocation in acute myeloid leukemia (AML), the result of which is the expression of the AML1-ETO (RUNX1-MTG8) fusion protein. AML1- ETO (AE) is composed of the N-terminal, DNA binding domain of the transcriptional regulator, AML1 (RUNX1) fused to the majority of the ETO (MTG8). Mtg8 is a member of a three protein family, including Mtg16 and Mtgr1, which function to mediate transcriptional repression through assembly of corepressor complexes at promoters through the interaction with sequence-specific transcription factors. Traditionally, AE expression is thought to contribute to leukemogenesis through the aberrant localization of the MTG8 transcriptional repressor at RUNX1 target genes required for normal blood development and stem cell self-renewal function. Interestingly, examination of human AML samples revealed that in addition to full length AE, an AE splice variant, termed AML1-ETO9a (AE9a) is detected at low levels. The AE9a splice variant encodes a C-terminal truncation, which in contrast to full length AE, is highly leukemogenic in mouse models. Such observations suggest that the C-terminal region of AE may impede leukemia development. Therefore, we carried out a yeast two-hybrid (Y2H) screen with a C-terminal fragment of Mtg protein to identify novel interacting partners that may account for the anti-leukemogenic function of the Mtg C-terminus. This screen identified novel interactions between Mtg proteins and a number of factors that regulate transcriptional elongation. Importantly, siRNAs directed towards these elongation factors complemented Mtg8-/- phenotypes, functionally linking these genes and suggesting that the regulation of elongation is a major function of MTGs. Moreover, inactivation of Mtg16 in blood cells increased genes that are regulated at the level of elongation to regulate stem cell self- renewal. Based on these preliminary data, we hypothesize that the C-terminal region of AE acts as an "anti- leukemogenic" domain by negatively affecting transcriptional elongation. Removal of this domain releases elongation factors to activate transcription at target genes such as HoxA5 and HoxA7. Our proposal seeks to fully elucidate both the molecular mechanism of MTG association with elongation factors as well as define the functional consequences of those interactions both in the context of "normal" cells as well as in the context of leukemogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRISPR-mediated Chemical Genetics Define Transcription Factor Gene Networks and Mechanisms of Control
CRISPR-mediated Chemical Genetics Define Transcription Factor Gene Networks and Mechanisms of Control
海外基金